Literature DB >> 19186111

Immunodiagnosis of human neurocysticercosis using a synthetic peptide selected by phage-display.

R C R Hell1, P Amim, H M de Andrade, R A M de Avila, L Felicori, A G Oliveira, C A Oliveira, E Nascimento, C A P Tavares, C Granier, C Chávez-Olórtegui.   

Abstract

The usefulness of a synthetic peptide in the serodiagnosis of Taenia solium human neurocysticercosis (NC) has been evaluated. Phage-displayed peptides were screened with human antibodies to scolex protein antigen from cysticercus cellulosae (SPACc). One clone was found to interact specifically with anti-SPACc IgGs. The corresponding synthetic peptide was found to be recognized in ELISA by NC patient's sera. The study was carried out with sera from 28 confirmed NC patients, 13 control sera and 73 sera from patients suffering from other infectious diseases. A 93% sensibility and a 94.3% specificity was achieved. Figures of 89% and 31.4% of sensibility and specificity were obtained in a SPACc-based ELISA. Immunoblotting of SPACc with anti-peptide antibodies revealed a single band of approximately 45 kDa in 1D and four 45 kDa isoforms in 2D-gel electrophoresis. A strong and specific immunostaining in the fibers beneath the suckers, at the base of the rostellum, and in the tissue surrounding the scolex of cysticerci was observed by immunomicroscopy. Our results show that a peptide-based immunodiagnostic of neurocisticercosis can be envisioned.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19186111     DOI: 10.1016/j.clim.2008.10.012

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  8 in total

1.  Neurocysticercosis.

Authors:  Pratibha Singhi
Journal:  Ther Adv Neurol Disord       Date:  2011-03       Impact factor: 6.570

2.  Serodiagnosis of Echinococcus spp. infection: explorative selection of diagnostic antigens by peptide microarray.

Authors:  Claudia List; Weihong Qi; Eva Maag; Bruno Gottstein; Norbert Müller; Ingrid Felger
Journal:  PLoS Negl Trop Dis       Date:  2010-08-03

Review 3.  Immunological and molecular diagnosis of cysticercosis.

Authors:  Silvia Rodriguez; Patricia Wilkins; Pierre Dorny
Journal:  Pathog Glob Health       Date:  2012-09       Impact factor: 2.894

Review 4.  Immunodiagnosis of neurocysticercosis: ways to focus on the challenge.

Authors:  M Esquivel-Velázquez; P Ostoa-Saloma; J Morales-Montor; R Hernández-Bello; C Larralde
Journal:  J Biomed Biotechnol       Date:  2011-10-29

5.  Use of Phage Display technology in development of canine visceral leishmaniasis vaccine using synthetic peptide trapped in sphingomyelin/cholesterol liposomes.

Authors:  Christina Monerat Toledo-Machado; Lilian Lacerda Bueno; Daniel Menezes-Souza; Ricardo Andrez Machado-de-Avila; Christophe Nguyen; Claude Granier; Daniella Castanheira Bartholomeu; Carlos Chávez-Olórtegui; Ricardo Toshio Fujiwara
Journal:  Parasit Vectors       Date:  2015-02-28       Impact factor: 3.876

6.  Immunodiagnosis of canine visceral leishmaniasis using mimotope peptides selected from phage displayed combinatorial libraries.

Authors:  Christina Monerat Toledo-Machado; Ricardo Andrez Machado de Avila; Christophe NGuyen; Claude Granier; Lilian Lacerda Bueno; Claudia Martins Carneiro; Daniel Menezes-Souza; Rubens Antonio Carneiro; Carlos Chávez-Olórtegui; Ricardo Toshio Fujiwara
Journal:  Biomed Res Int       Date:  2015-01-29       Impact factor: 3.411

7.  Cysticercus cellulosae antigens in the serodiagnosis of neurocysticercosis.

Authors:  Subhash Chandra Parija; Ar Gireesh
Journal:  Trop Parasitol       Date:  2011-07

Review 8.  Pediatric neurocysticercosis: current challenges and future prospects.

Authors:  Pratibha Singhi; Arushi Gahlot Saini
Journal:  Pediatric Health Med Ther       Date:  2016-03-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.